CRSP Reports CARBON Trial Data, NK's COVID-19 Vaccine Study Chugs Along, ZSAN Slips As FDA Says "No"

Today's Daily Dose brings you news about FDA denying approval to Zosano Pharma's migraine treatment; CRISPR Therapeutics' CARBON trial results; and the progress in NantKwest's COVID-19 vaccine candidate.

from RTT - Biotech https://ift.tt/3mbNXhs
via IFTTT